Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2015-11-30
2016-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Liberal Versus Restrictive Transfusion During Symptomatic Moderate Anemia After Hip Arthroplasty
NCT01452581
Transfusion Rates in Total Hip Replacement Before/After the Implementation of a Patient Blood Management Program.
NCT04398238
Topical Application of Tranexamic Acid Reduces Postoperative Blood Loss in Total Hip Arthroplasty
NCT01260818
Use of Transexamic Acid in Hip Replacement
NCT02587845
Postoperative Blood Transfusion for Frail Elderly With Hip Fracture
NCT01102010
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RBC_old
shelf life of red blood cells of 15 or higher days
Old red blood cells transfusion
Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty)
RBC_new
shelf life of red blood cells 14 or lower days
New red blood cells transfusion
Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Old red blood cells transfusion
Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty)
New red blood cells transfusion
Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients who were given two units of which one unit was old and one was new
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyun-Jung Shin
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-1510/318-112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.